The purpose of the current study was to explore the suitability of nanostructured lipid carriers
(NLCs) loaded with a model drug calycosin for the treatment of breast cancer. NLCs were …

Pioglitazone (PGZ) is utilized as a therapeutic agent in the management of (type 2) diabetes
to control blood glucose levels. The existing research work was intended to make and …

The purpose of the present study was to design nanostructured lipid carriers (NLCs)
exhibiting improved mucoadhesive properties. First, an S-protected thiolated fatty acid …

Osteoporosis is a common metabolic disorder associated with global morbidities and
mortalities which make it a big challenge to the public health. Despite the availability of a …

In this study, we report the highly responsive chitosan-based chemically cross-linked
nanomatrices, a nano-version of hydrogels developed through modified polymerization …

Simvastatin (SVA) is a well-prescribed drug for treating cardiovascular and
hypercholesterolemia. Due to the extensive hepatic first-pass metabolism and poor …

Phospholipid complexation, despite being a successful, versatile, and burgeoning strategy,
stickiness of phospholipids leads to suboptimal dissolution rate of drugs. This work was …

Although colloidal carriers have been in the pipeline for nearly four decades, standardized
methods for testing their drug-release properties remain to be established in …

The objective of the study was to design mucoadhesive drug-loaded nanostructured lipid
carriers (NLCs) for enhancing the bioavailability of a model BCS Class IV drug aprepitant …

The major goal of this project was to formulate iodine-based self nano-emulsifying drug
delivery system to provide improve antimicrobial activity and enhanced mucosal residence …